Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD by Dong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, Jae Sook Ahn, Hyeoung-Joon Kim, Sung Nam Lim, Jun Won Cheong, Sung-Yong Kim, Ho Sup Lee, Jong Ho Won, Ho-Young Yhim, Sang Kyun Sohn, Joon Ho Moon

Get full text

Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea by Da Jung Kim, Seri Jeong, Seom Gim Kong, Sangjin Lee, Sung-Nam Lim, Sung Yong Oh, Young Rok Do, Won Sik Lee, Mark Hong Lee, Sung Hwa Bae, Se Hyung Kim, Min Kyoung Kim, Ho Sup Lee, Consortium for Improving Survival of Lymphoma (CISL)

Get full text

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial by Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok-Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung-Soo Yoon, Youngil Koh

Get full text

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study by Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin, Cheolwon Suh

Get full text

Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation by Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, Ka-Won Kang, Ho Sup Lee, Hyeon-Seok Eom, Enuyoung Lee, Ji Hyun Lee, Jeong-Ok Lee, Seong Kyu Park, Seok Jin Kim, Keon Hee Yoo, Sung-Soo Yoon, Youngil Koh, Hyoung Jin Kang, Jong-Ho Won, Chuhl Joo Lyu, Seung Min Hahn, Jung-Hee Lee, Joon Seong Park, Jae-Cheol Jo, Yeung-Chul Mun, Deok-Hwan Yang, Ga-Young Song, Sung-Nam Lim, Sang Kyun Sohn, The Korean Society of Blood and Marrow Transplantation

Get full text

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation by Seok Jin Kim, Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, Deok-Hwan Yang, Sang Eun Yoon, Gyeong-Won Lee, Jee Hyun Kong, Jee Hyun Kong, Yong Park, Ka-Won Kang, Ho-Sup Lee, Sung Yong Oh, Ho-Jin Shin, Won Sik Lee, Yoon Seok Choi, Seong Hyun Jeong, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Sung-Nam Lim, Ho-Young Yhim, Young Rok Do, Hwan Jung Yun, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, Won Seog Kim, Won Seog Kim

Get full text